Dr Reddy’s Launches Cheaper Version of Antibiotic Avelox in US

by Anubha Sinha on  March 6, 2014 at 6:07 PM Drug News
RSS Email Print This Page Comment bookmark
Font : A-A+

Dr Reddy's Laboratories said that after a nod from United States Food & Drug Administration (USFDA) it has launched Moxifloxacin Hydrochloride Tablets 400 mg in the US.
 Dr Reddy’s Launches Cheaper Version of Antibiotic Avelox in US
Dr Reddy’s Launches Cheaper Version of Antibiotic Avelox in US

In the US, Moxifloxacin will be the cheaper version of antibiotic drug Avelox, which is manufactured by Bayer AG and distributed by Merck. The other two firms with approval of this drug are Teva and Aurobindo Pharma.

According to IMS Health, for the year ending December 2013 Avelox brand had US sales of approximately $195 mn.

Last week, Dr Reddy's Laboratories launched anti-migraine sumatriptan injection in the US which clocked $169-million sales in 2013.

Moxifloxacin is an antibiotic which is used for treating acute bacterial sinusitis, bronchitis, skin and abdominal infections.

Source: Medindia

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

Related Links

More News on:

MRSA - The Super Bug Drug Resistance - Antibiotic Resistance Antibiotics Eye Infections Natural Antibiotics to Fight Bacterial Infections 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor
Advertisement

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive